Ulcerating necrobiotic xanthogranuloma: A clinical sign to reconsider progression from MGUS to multiple myeloma
- PMID: 37663892
- PMCID: PMC10470407
- DOI: 10.1016/j.jdcr.2023.07.024
Ulcerating necrobiotic xanthogranuloma: A clinical sign to reconsider progression from MGUS to multiple myeloma
Keywords: MGUS; NXG; monoclonal gammopathy of undetermined significance; multiple myeloma; necrobiotic xanthogranuloma.
Conflict of interest statement
The authors declare no conflicts of interest with respect to the research, authorship, and/or publication of this article. Nicole R. LeBoeuf is a consultant and has received honoraria from Bayer, Seattle Genetics, Sanofi, Silverback, Fortress Biotech, and Synox Therapeutics outside the scope of the submitted work.
Figures
References
-
- Wood A.J., Wagner M.V., Abbott J.J., Gibson L.E. Necrobiotic xanthogranuloma: a review of 17 cases with emphasis on clinical and pathologic correlation. Arch Dermatol. 2009;145(3):279–284. - PubMed
-
- Fernandez-Herrera J., Pedraz J. Necrobiotic xanthogranuloma. Semin Cutan Med Surg. 2007;26(2):108–113. - PubMed
-
- Bullock J.D., Bartley G.B., Campbell R.J., Yanes B., Connelly P.J., Funkhouser J.W. Necrobiotic xanthogranuloma with paraproteinemia. Case report and a pathogenetic theory. Ophthalmology. 1986;93(9):1233–1236. - PubMed
-
- Matsuura F., Yamashita S., Hirano K., et al. Activation of monocytes in vivo causes intracellular accumulation of lipoprotein-derived lipids and marked hypocholesterolemia--a possible pathogenesis of necrobiotic xanthogranuloma. Atherosclerosis. 1999;142(2):355–365. - PubMed
Publication types
LinkOut - more resources
Full Text Sources